A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial Fibrillation
Clinical trial NCT07217067 · RECRUITING
Trial details
- NCT number
- NCT07217067
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-28
- Primary completion
- 2027-09-09
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.